The fusion of the TMPRSS2 gene with E-twenty six (ETS) family genes like ETV1, ERG and ETV4 occurs in up to 70% of all prostate cancers and is therefore a specific biomarker for prostate cancer diagnostics (Perner et al., 2007). This evidence concerns the gene ERG and Familial prostate cancer.